Evidence map›Paper›PMID 41156600›Full record

ReviewPathogens (Basel, Switzerland)2025

Mechanisms of Interleukin-10-Mediated Immunosuppression in Viral Infections.

Zijing Guo, Qifu He, Yan Zhang, Yuling Li, Zhidong Zhang

Abstract readReview
In one paragraph

Review in Pathogens (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Anti-Inflammatory Interleukins in the Pathogenesis of Atherosclerosis.International journal of molecular sciences · 2026
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Observational
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zijing GuoKey Laboratory of Veterinary Medicine in Universities of Sichuan Province, College of Animal Science and Veterinary Medicine, Southwest Minzu University, Chengdu 610041, China.ORCID 0000-0002-2291-700X
Qifu HeWuhou District Health Hospital for Women & Children, Chengdu 610041, China.
Yan ZhangKey Laboratory of Veterinary Medicine in Universities of Sichuan Province, College of Animal Science and Veterinary Medicine, Southwest Minzu University, Chengdu 610041, China.
Yuling LiKey Laboratory of Veterinary Medicine in Universities of Sichuan Province, College of Animal Science and Veterinary Medicine, Southwest Minzu University, Chengdu 610041, China.
Zhidong ZhangKey Laboratory of Veterinary Medicine in Universities of Sichuan Province, College of Animal Science and Veterinary Medicine, Southwest Minzu University, Chengdu 610041, China.ORCID 0000-0002-2186-7661

Funding

National Key Research and Development Program of China 2024YFD1800503Sichuan Province Science and Technology Planning Project 2024NSFSC1274Southwest Minzu University Research Startup Funds RQD2023001
6 · The paper itself

Abstract

Interleukin-10 (IL-10), a potent anti-inflammatory cytokine, plays a vital role in regulating immune responses across various infectious and inflammatory conditions. While IL-10 is essential for preventing excessive tissue damage and maintaining immune homeostasis (e.g., respiratory syncytial virus), its elevated levels could result in immunosuppression during viral infections, enabling viruses to evade host defenses (e.g., foot-and-mouth disease virus). This review aims to elucidate the mechanisms through which IL-10 mediates immunosuppression in viral infections and to explore the implications of these mechanisms for therapeutic intervention. The key scientific concepts outlined in this review include the mechanisms of IL-10 production and its varied impacts on the immune response during viral infections. Specifically, we discuss the multifaceted inhibitory effects of IL-10 on innate and adaptive immunity, including its implications for antigen presentation, T cells activation, pro-inflammatory cytokine production, immune cell differentiation, trafficking, apoptosis, and co-inhibitory expression related to T cells exhaustion. Finally, we discuss the therapeutic potential of targeting IL-10, such as monoclonal antibodies and small molecule inhibitors, and their potential to restore effective immune responses. By summarizing current knowledge on IL-10's role in viral infections, this review offers a thorough insight into its immunosuppressive mechanisms and their therapeutic potential, paving the way for innovative treatment strategies in viral diseases.

Indexed as

Immune ToleranceInterleukin-10Virus DiseasesAdaptive ImmunityAnimalsHumansImmunity, InnateT-LymphocytesInterleukin-10immunosuppressioninnate and adaptive immunityinterleukin-10therapeutic interventionviral infections

Identifiers

PMID41156600
PMCPMC12567269

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.